Menu
Recruiting NCT07442175

Blood Pressure Monitor (TH-75) Atrial Fibrillation Detection Function Clinical Trial

— Observational Atrial Fibrillation (AF)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Atrial Fibrillation (AF). Basic parameters: from 22 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

This study evaluates the accuracy of a blood pressure monitor in detecting atrial fibrillation by comparing its results with a standard diagnostic method.

Primary outcome measures

  • Accuracy of atrial fibrillation detection by the TH-75 blood pressure monitor, assessed against the prespecified acceptance criteria. [Time frame: Baseline]

Eligibility criteria

Inclusion criteria

Atrial Fibrillation (AF):

  • Age ≥ 22 years;
  • Arm circumference between 22 cm and 42 cm;
  • Diagnosed with atrial fibrillation by a qualified medical institution.

Non-Atrial Fibrillation:

  • Age ≥ 22 years;
  • Arm circumference between 22 cm and 42 cm;
  • No prior diagnosis of atrial fibrillation.

Exclusion criteria

  • Pregnant women
  • Presence of an implanted cardiac pacemaker and/or defibrillator
  • Inability to cooperate with blood pressure measurement or ECG assessment
  • Any condition that, in the opinion of the investigator, makes the participant unsuitable for participation in this clinical study

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Other

Study locations

China · 1 center
  • First Teaching Hospital of Tianjin University of Traditional Chinese Medicine — Tianjin

Identifiers

NCT: NCT07442175 · Andon Health 18

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗